Sprout Pharmaceuticals, Inc.
PrivateLast Round
VC Round
Sep 4, 2019
Est. Valuation
$1B
Total Funding Raised
$130M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Sprout Pharmaceuticals, Inc. operates in Healthcare & Life Sciences and is based in Raleigh, North Carolina. Its latest recorded funding round was a VC Round in September 2019.
Sprout Pharmaceuticals, Inc. is a pharmaceutical company that develops and markets treatments for women's sexual health, most notably the FDA-approved medication Addyi for the treatment of Hypoactive Sexual Desire Disorder (HSDD).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Patient Engagement, Clinical Trials
Business Model
B2B2C
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sprout Pharmaceuticals, Inc. Comparables
Compare Sprout Pharmaceuticals, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cosette Pharmaceuticals, Inc. | 80% | |
| S1 Biopharma, Inc. | 74% | |
| Freya Pharma Solutions | 71% |
For institutional investors. Book with your work email.
Sprout Pharmaceuticals, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 4, 2019 | ||||
| Debt | Nov 6, 2017 | ||||
| M&A | Aug 20, 2015 | ||||
| Series C | Jun 8, 2015 | ||||
| Series B | Jul 11, 2014 | ||||
Series A | Jun 25, 2013 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 48% MoM.
- Jan 29, 2026
Attended the 2026 Oprah Daily Menopause O-wards.
For institutional investors. Book with your work email.
Sprout Pharmaceuticals, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sprout Pharmaceuticals, Inc.'s valuation, stock price, and market status.
Is Sprout Pharmaceuticals, Inc. a public or private company?
Sprout Pharmaceuticals, Inc. is a private company.
What is the current stock price of Sprout Pharmaceuticals, Inc.?
Sprout Pharmaceuticals, Inc. is a private company, so its shares have no public market price. Caplight tracks Sprout Pharmaceuticals, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sprout Pharmaceuticals, Inc. worth (valuation)?
Sprout Pharmaceuticals, Inc.'s valuation is estimated at $1.0B based on funding round data.
Can I buy Sprout Pharmaceuticals, Inc. stock?
Sprout Pharmaceuticals, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sprout Pharmaceuticals, Inc.'s last funding round?
Sprout Pharmaceuticals, Inc.'s most recent funding round was VC Round on September 4, 2019.
Who are the main investors in Sprout Pharmaceuticals, Inc.?
Investor information for Sprout Pharmaceuticals, Inc. is not publicly disclosed.
Will Sprout Pharmaceuticals, Inc. IPO soon?
No public IPO plans have been announced for Sprout Pharmaceuticals, Inc..
How can I track Sprout Pharmaceuticals, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Sprout Pharmaceuticals, Inc.'s shares on secondary markets.